Home › Companies › Teva Pharmaceutical Industries Limited › 2025-2026
Compiled from SEC Form N-PX filings and Teva Pharmaceutical Industries Limited’s Form 8-K, filed May 28, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of May 28, 2026: 3 items on Teva Pharmaceutical Industries Limited’s Form 8-K, filed May 28, 2026: 2 approved · 1 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Teva Pharmaceutical Industries Limited in the interactive database Compare manager voting policies
These tallies are Teva Pharmaceutical Industries Limited’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 28, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Sol J. Barer | 627,816,662 | 245,921,571 | 530,682 | -- | 50,661,570 | 72% | Not verified | — |
| 2. On a non-binding advisory basis, the compensation for Teva's named executive officers listed in the proxy statement for the Annual Meeting | 795,976,042 | 77,082,847 | 1,170,026 | -- | 50,661,570 | 91% | Approved | — |
| 3. The appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2027 annual meeting of shareholders | 880,542,242 | 36,085,507 | 525,382 | -- | 0 | 96% | Approved | — |
Source: Teva Pharmaceutical Industries Limited, Form 8-K, filed with the SEC on May 28, 2026 — read the filing on EDGAR.
Each item below shows how the 619 asset managers that disclosed a Teva Pharmaceutical Industries Limited vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Teva Pharmaceutical Industries Limited’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Description as filed by funds: To appoint Dr. Sol J. Barer to serve as a director until Teva's 2029 Annual Meeting of Shareholders
Teva Pharmaceutical Industries Limited’s own tally for this item (“Elect Director: Dr. Sol J. Barer”): 627,816,662 for, 245,921,571 against, per its Form 8-K filed May 28, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 109 asset managers below reported 155,718,632 for, 2,045,492 against, 59,891 abstained, 336,890 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 31,361,106 | 0 | 0 | 0 | For |
| Vanguard | 31,267,716 | 0 | 0 | 0 | For |
| BlackRock | 27,277,644 | 0 | 0 | 0 | For |
| Investment Managers Series Trust | 13,399,660 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 5,843,812 | 0 | 0 | 0 | For |
| Capital Group | 5,011,035 | 0 | 0 | 0 | For |
| Charles Schwab | 4,414,989 | 0 | 0 | 0 | For |
| TIAA | 2,550,548 | 0 | 0 | 0 | For |
| Jackson National | 2,511,684 | 16,909 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 2,446,446 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 2,353,527 | 0 | 0 | 0 | For |
| Lord Abbett | 2,232,424 | 0 | 0 | 0 | For |
| Hartford | 2,050,890 | 0 | 0 | 0 | For |
| State Street | 2,047,360 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,036,647 | 0 | 0 | 0 | For |
| Invesco | 1,876,080 | 0 | 0 | 0 | For |
| Victory Capital | 1,767,838 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 1,448,890 | 0 | 0 | 0 | For |
| SOUND SHORE FUND INC | 1,269,505 | 0 | 0 | 0 | For |
| First Trust | 1,160,521 | 0 | 0 | 0 | For |
| Prudential/PGIM | 996,900 | 0 | 0 | 0 | For |
| Allspring | 907,121 | 0 | 0 | 0 | For |
| Dimensional | 0 | 892,174 | 0 | 0 | Against |
| DWS | 615,337 | 0 | 0 | 0 | For |
| MARSICO INVESTMENT FUND | 574,218 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 24 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION FOR TEVA'S NAMED EXECUTIVE OFFICERS
Teva Pharmaceutical Industries Limited’s own tally for this item (“2. On a non-binding advisory basis, the compensation for Teva's named executive officers listed in the proxy statement for the Annual Meeting”): 795,976,042 for, 77,082,847 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) The shareholders approved, on a non-binding advisory basis, the compensation for Teva's named executive officers listed in the proxy statement for the Annual Meeting, as follows:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 31,361,106 | 0 | 0 | 0 | For |
| Vanguard | 31,267,716 | 0 | 0 | 0 | For |
| BlackRock | 27,277,644 | 0 | 0 | 0 | For |
| Investment Managers Series Trust | 13,399,660 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 5,843,812 | 0 | 0 | 0 | For |
| Capital Group | 5,011,035 | 0 | 0 | 0 | For |
| Charles Schwab | 4,414,989 | 0 | 0 | 0 | For |
| TIAA | 2,550,548 | 0 | 0 | 0 | For |
| Jackson National | 2,528,593 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 2,446,446 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 2,353,527 | 0 | 0 | 0 | For |
| Lord Abbett | 2,232,424 | 0 | 0 | 0 | For |
| Hartford | 2,050,890 | 0 | 0 | 0 | For |
| State Street | 2,047,360 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,036,647 | 0 | 0 | 0 | For |
| Invesco | 1,876,080 | 0 | 0 | 0 | For |
| Victory Capital | 1,767,838 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 1,448,890 | 0 | 0 | 0 | For |
| SOUND SHORE FUND INC | 1,269,505 | 0 | 0 | 0 | For |
| First Trust | 1,160,521 | 0 | 0 | 0 | For |
| Prudential/PGIM | 996,900 | 0 | 0 | 0 | For |
| Allspring | 907,121 | 0 | 0 | 0 | For |
| Dimensional | 892,174 | 0 | 0 | 0 | For |
| DWS | 615,337 | 0 | 0 | 0 | For |
| MARSICO INVESTMENT FUND | 574,218 | 0 | 0 | 0 | For |
Fund voting reports, all 103 managers: 157,511,409 for, 11,884 against, 59,891 abstained, 336,890 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 77,246,886 | 0 | 0 | 0 | For |
| Migdal Insurance & Financial Holdings Ltd. | 60,694,120 | 0 | 0 | 0 | For |
| Phoenix Financial Ltd. | 54,504,019 | 0 | 0 | 0 | For |
| MENORA MIVTACHIM HOLDINGS LTD. | 53,937,202 | 0 | 0 | 0 | For |
| BlackRock | 42,982,241 | 0 | 0 | 0 | For |
| Clal Insurance Enterprises Holdings Ltd | 37,718,089 | 0 | 0 | 0 | For |
| Fidelity | 33,312,389 | 0 | 0 | 0 | For |
| State Street | 15,854,197 | 58,957 | 0 | 0 | For |
| Vanguard | 12,682,712 | 0 | 0 | 0 | For |
| Capital Group | 11,674,171 | 0 | 0 | 0 | For |
| Altshuler Shaham Ltd | 0 | 11,463,884 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 10,605,632 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 10,209,344 | 0 | 0 | 0 | For |
| Janus Henderson | 9,449,845 | 0 | 0 | 0 | For |
| Y.D. More Investments Ltd | 0 | 8,426,222 | 0 | 0 | Against |
| Northern Trust | 6,591,426 | 0 | 0 | 0 | For |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 6,148,015 | 0 | 0 | 0 | For |
| Wellington | 5,658,324 | 0 | 0 | 0 | For |
| Invesco | 5,431,147 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 63,840 | 4,990,570 | 0 | 0 | Against |
| Charles Schwab | 4,620,851 | 0 | 0 | 0 | For |
| ION Fund Management Ltd | 3,883,183 | 0 | 0 | 0 | For |
| AustralianSuper Pty Ltd | 0 | 3,793,078 | 0 | 0 | Against |
| Alyeska Investment Group, L.P. | 3,773,343 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 3,554,159 | 0 | 0 | 0 | For |
Institutional-manager reports, all 542 managers: 562,576,658 for, 41,765,418 against, 352,705 abstained, 28,591 not voted, 585,954 1 year. Showing the 25 largest; see all in the interactive database.
Combines 6 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS TEVA'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL TEVA'S 2027 ANNUAL MEETING OF SHAREHOLDERS
Teva Pharmaceutical Industries Limited’s own tally for this item (“3. The appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2027 annual meeting of shareholders”): 880,542,242 for, 36,085,507 against — passed, per its Form 8-K filed May 28, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(3) The shareholders approved the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2027 annual meeting of shareholders, as follows:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 107 asset managers below reported 156,015,752 for, 809,305 against, 59,891 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 31,361,106 | 0 | 0 | 0 | For |
| Vanguard | 31,267,716 | 0 | 0 | 0 | For |
| BlackRock | 27,277,644 | 0 | 0 | 0 | For |
| Investment Managers Series Trust | 13,399,660 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 5,843,812 | 0 | 0 | 0 | For |
| Capital Group | 5,011,035 | 0 | 0 | 0 | For |
| Charles Schwab | 4,414,989 | 0 | 0 | 0 | For |
| TIAA | 2,550,548 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 2,446,446 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 2,353,527 | 0 | 0 | 0 | For |
| Jackson National | 2,333,740 | 0 | 0 | 0 | For |
| Lord Abbett | 2,232,424 | 0 | 0 | 0 | For |
| Hartford | 2,049,659 | 1,231 | 0 | 0 | For |
| State Street | 2,047,360 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,036,647 | 0 | 0 | 0 | For |
| Invesco | 1,876,080 | 0 | 0 | 0 | For |
| Victory Capital | 1,767,838 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 1,448,890 | 0 | 0 | 0 | For |
| SOUND SHORE FUND INC | 1,269,505 | 0 | 0 | 0 | For |
| First Trust | 1,160,521 | 0 | 0 | 0 | For |
| Prudential/PGIM | 996,900 | 0 | 0 | 0 | For |
| Allspring | 907,121 | 0 | 0 | 0 | For |
| Dimensional | 892,174 | 0 | 0 | 0 | For |
| DWS | 615,337 | 0 | 0 | 0 | For |
| MARSICO INVESTMENT FUND | 574,218 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 0 | 0 | 0 | 0 | Not Voted |
| Empower | 209,104 | 0 | 0 | 0 | For |
Fund voting reports, all 2 managers: 209,104 for, 336,890 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Dorsey Wright & Associates | 240,674 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 240,674 for.
100% of fund votes cast · no official result
The 3 asset managers below reported 489,289 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Tidal Trust IV | 216,116 | 0 | 0 | 0 | For |
| Jackson National | 194,853 | 0 | 0 | 0 | For |
| John Hancock | 78,320 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,164,426,972 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 2.69% |
| 2 | Vanguard | 2.69% |
| 3 | BlackRock | 2.34% |
| 4 | Investment Managers Series Trust | 1.15% |
| 5 | NEW ECONOMY FUND | 0.50% |
| 6 | Capital Group | 0.43% |
| 7 | Charles Schwab | 0.38% |
| 8 | TIAA | 0.22% |
| 9 | Jackson National | 0.22% |
| 10 | OLD WESTBURY FUNDS INC | 0.21% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Harel Insurance Investments & Financial Services Ltd. | 6.63% |
| 2 | Migdal Insurance & Financial Holdings Ltd. | 5.21% |
| 3 | Phoenix Financial Ltd. | 4.68% |
| 4 | MENORA MIVTACHIM HOLDINGS LTD. | 4.63% |
| 5 | BlackRock | 3.69% |
| 6 | Clal Insurance Enterprises Holdings Ltd | 3.24% |
| 7 | Fidelity | 2.86% |
| 8 | State Street | 1.37% |
| 9 | Vanguard | 1.09% |
| 10 | Capital Group | 1.00% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Harel Insurance Investments & Financial Services Ltd | 6.21% | 13G |
| BlackRock | 5.59% | 13F |
| Migdal Insurance & Financial Holdings Ltd | 5.30% | 13G |
| FMR (Fidelity) | 2.85% | 13F |
| State Street | 1.53% | 13F |
| Geode Capital | 0.91% | 13F |
| Morgan Stanley | 0.73% | 13F |
| Northern Trust | 0.66% | 13F |
| Wellington Management | 0.62% | 13F |
| JPMorgan Chase | 0.58% | 13F |
Percentages above are of 1,164,426,972 shares outstanding, as reported by Teva Pharmaceutical Industries Limited on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Teva Pharmaceutical Industries Limited’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At Teva Pharmaceutical Industries Limited's shareholder meeting held May 28, 2026, in the 2025-2026 proxy season, 619 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,845 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION FOR TEVA'S NAMED EXECUTIVE… — Teva Pharmaceutical Industries Limited's filing reports the proposal as approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Teva Pharmaceutical Industries Limited's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 28, 2026.
Teva Pharmaceutical Industries Limited proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.